Literature DB >> 6180343

[Interferon therapy for malignant brain tumors-present and future (author's transl)].

M Nagai, T Arai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6180343

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN： 0301-2603


× No keyword cloud information.
  7 in total

1.  Local immunotherapy (beta-IFN) and systemic chemotherapy in primary glial tumors.

Authors:  A Boiardi; A Silvani; I Milanesi; L Munari; G Broggi; M Botturi
Journal:  Ital J Neurol Sci       Date:  1991-04

Review 2.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

3.  Distribution of mouse interferon-beta in normal and brain tumour-bearing mice.

Authors:  Y Mihara; J Kuratsu; S Takaki; K Hori; E Nagai; Y Satoh; N Minowa; Y Ushio
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

5.  Effect of interferon-beta on the cell cycle of human glioma cell line U-251 MG: flow cytometric two-dimensional (BrdU/DNA) analysis.

Authors:  S Genka; N Shitara; Y Tsujita; Y Kosugi; K Takakura
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130

6.  Flow cytometric analysis of antineoplastic effects of interferon-alpha, beta and gamma labelled with fluorescein isothiocyanate on cultured brain tumors.

Authors:  Y Numa; K Kawamoto; N Sakai; H Matsumura
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

7.  Single agent therapy of interferon for brain tumours: correlation between natural killer activity and clinical course.

Authors:  S Otsuka; H Handa; J Yamashita; K Suda; J Takeuchi
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.